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SOFTWARE DISCLOSURE AND LIABILITY UNDER THE SECURITIES ACTS
Introduction
Can a software company be liable under the securities laws when it sells securities
without disclosing that it will not give free updates on current software as new
technology makes them obsolete? What exactly must be disclosed and how does one say
it without subjecting the company's business practices to close scrutiny? The Eleventh
Circuit recently applied the time-honored standard of meaningful cautionary language to
software companies in finding that the disclosures of a software company were enough
to avoid liability under the securities laws when the company provided meaningful
cautionary language in their prospectus.1 
Ehlert v. Singer
¶ 1          Medical Manager Corporation was one of the leading providers of software to the 
healthcare industry. Among other things, they provided computer management systems to the 
health care industry. Most of their sales, and thus most of their revenues, were derived from their 
product known as Medical Manager, a practice management system. In 1994, Medical Manager 
Corporation began selling "Version 8" of its Medical Manager software. In February 1997, 
Medical Manager Corporation made an initial public offering and thus became a publicly traded 
company subject to the provisions of the Securities Act of 1933 and the Securities and Exchange 
Act of 1934. In 1997 Medical Manager Corporation also released "Version 9" of its Medical 
Manager software. Version 9 was the first version of Medical Manager Corporation's Medical 
Manager software that was year 2000 compliant. On April 23, 1998, Medical Manager 
Corporation conducted a secondary public offering at an offering price of $30 per share, selling 
2.5 million shares. On August 5, 1998, information circulated publicly that a class action lawsuit 
had been filed against Medical Manager Corporation for its refusal to provide free upgrade 
service for its Version 8 software in order to make that software year 2000 compliant. News of 
this lawsuit and Medical Manager Corporation's refusal to provide the software upgrades drove 
the stock price of Medical Manager Corporation down from $26.75 per share to $20.375 per
share.
¶ 2          On August 31, 1998, Medical Manager Corporation issued a statement saying it was
"no longer enhancing, updating or maintaining versions prior to Version 9" and that it would
make "no representations with respect thereto, including those concerning the current or future
ability of Version 8 or prior versions to handle industry and regulatory requirements."2 A group
of shareholders then filed suit for shares they had purchased on or about April 24, 1998, at the
offering price of $30 per share. The Plaintiffs alleged that "[d]efendants' issuance of materially
false and misleading statements and omissions in the prospectus and registration statement,
issued as part of the secondary public offering, caused the class to purchase the stock at
artificially inflated prices."3 The Plaintiffs' major claim was that the prospectus filed as part of
MMC's registration statement was materially false and misleading for failing to state that
MMC's Version 8 would no longer be enhanced or upgraded and that Version 9 would
essentially render it obsolete.
Legal Basis for the Claim
¶ 3          The Plaintiffs based their claim on Sections 11 and 12(a)(2) of the Securities Act of 
1933. Section 11 of the Act allows for a private cause of action where a registration statement 
either "contained an untrue statement of a material fact or omitted to state a material fact 
required to be stated therein or necessary to make the statements therein not 
misleading."4 Section 12(a)(2) allows for a private cause of action against those who either offer 
or sell a security "which includes an untrue statement of a material fact or omits to state a 
material fact necessary in order to make the statements, in the light of the circumstances under 
which they were made, not misleading."5 Section 12 liability extends to those who transfer title 
to the security and to those who successfully solicit for profit the purchase of the security.6 In 
order for the Plaintiffs to state a cause of action, they had to provide evidence that MMC made a 
material misstatement or omission in its prospectus that was filed in conjunction with the 
registration statement. The Plaintiffs pointed to two statements made in the prospectus that they 
alleged led to the material misstatement. First the Plaintiffs alleged that MMC made a 
misleading statement by saying, "the Company's future success will depend, in part, upon its 
ability to enhance its current products, to respond effectively to technological changes, to sell 
additional products to its existing client base and to introduce new products and technologies 
that address the increasingly sophisticated needs of its clients."7 Second, Plaintiffs alleged that 
MMC's statement that "the Company is devoting significant resources to the development of 
enhancements to its existing products and the migration of existing products to new software
platforms"8 was misleading. The Plaintiffs argued that by making these statements without
disclosing the company's lack of intent to provide upgrades for Version 8, thereby essentially
making it obsolete upon the introduction of Version 9, MMC made materially misleading
statements.
¶ 4          The Private Securities Litigation Reform Act of 1995 (PSLRA) provides a "Safe
Harbor" to companies for certain forward-looking statements.9 Since MMC's statements fall into
the PSLRA's definition of forward-looking statements they will fall into this safe harbor so long
as they are surrounded by meaningful cautionary language. In its prospectus, MMC informed
investors "the market for the Company's products is characterized by rapid change and
technological advances requiring ongoing expenditures for research and development and the
timely introduction of new products and enhancements of existing products."10 MMC also
warned investors that "there can be no assurance that the Company will successfully complete
the development of new products or that the Company's current or future products will satisfy
the needs of the market for practice management systems."11 MMC also provided the following
cautionary language.
"Any failure of the Company's products to provide accurate, confidential and timely 
information, including failures which may be traceable to the Year 2000 issue, could 
result in product liability or breach of contract claims against the Company by its clients, 
their patients or others . . . There can be no assurance that the Company will not be 
subject to product liability or breach of contract claims . . . the Year 2000 issue relates to 
whether computer systems will properly recognize and process information relating to 
dates in and after the year 2000. These systems could fail or produce erroneous results if 
they cannot adequately process dates beyond the year 1999 and are not corrected. 
Significant uncertainty exists in the software industry concerning the potential 
consequences that may result from failure of software to adequately address the Year 
2000 issue. The Year 2000 issue also creates risk for the Company from problems that 
may be experienced by customers of its software. While the Company believes that 
Version 9 of The Medical Manager practice management system, which was 
commercially released in November 1997, is Year 2000 compliant, prior versions of the 
system are not. The Company has encouraged users of pre-Version 9 versions of the 
Medical Manager software to upgrade to Version 9 in order to become Year 2000 
compliant. If these or other customers experience significant difficulties as a result of the 
Year 2000 issue, or if the Company encounters difficulties in responding in a timely 
manner to customer requests to upgrade to Version 9, there could be a material adverse
impact on the Company's results of operations, financial condition or business."12 
¶ 5          Because the Court found the preceding language to be meaningful cautionary language
within the meaning of the PSLRA, MMC's statements fell in the safe harbor and were not
materially false or misleading. In making this decision the Court stated that, in order to qualify
for the safe harbor provided by the PSLRA, the cautionary language must only mention
"important factors that could cause actual results to differ materially from those in the
forward-looking statement."13 There is no requirement that the prospectus list every factor that
may influence the company's financial future.14 The meaningful cautionary language need not
explicitly mention the factor that eventually causes the company's loss. The company must only
list dangers generally similar to the one the company eventually faces. "When an investor has
been warned of risks of a significance similar to that actually realized, she is sufficiently on
notice of the danger of the investment to make an intelligent decision about it according to her
own preferences for risk and reward."15 
Conclusion
¶ 6          As technology continues to grow at a rapid pace, businesses must be alert to the need
for meaningful cautionary language in their prospectuses concerning the possibility of their
current products becoming obsolete. Although meaningful cautionary language may not protect
a company from a lawsuit, if the language is adequate it will protect them from liability under
the securities laws by preventing their prospectuses from containing materially false and
misleading statements.
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